Evaluation of methods for cultivating limbal mesenchymal stromal cells

Cytotherapy

Volumn 14, Issue 8, 2012, Pages 936-947

  Bray, Laura J ^a,b   Heazlewood, Celena F ^c,d   Atkinson, Kerry ^c,d   Hutmacher, Dietmar W ^b   Harkin, Damien G ^a,b  

^a QUEENSLAND EYE INSTITUTE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cornea; Epithelium; Keratocytes; Limbus; Mesenchymal stromal cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN 3; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CD34 SELECTION; CELL ASSAY; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA LIMBUS; COW; CULTURE MEDIUM; CULTURE TECHNIQUE; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; NONHUMAN; PHOTOGRAPHY; PRIORITY JOURNAL; SERUM;

EID: 84865764180     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.684379     Document Type: Article

References (25)

1. Schermer A, Galvin S, Sun TT. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol. 1986;103:49-62.
2. Grueterich M, Espana EM, Touhami A, Ti SE, Tseng SC. Phenotypic study of a case with successful transplantation of ex vivo expanded human limbal epithelium for unilateral total limbal stem cell deficiency. Ophthalmology. 2002;109:1547-52.
3. Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology. 2001;108:1569-74.
4. Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. New Engl J Med. 2000;343:86-93.
5. Harkin DG, Barnard Z, Gillies P, Ainscough SL, Apel AJ. Analysis of p63 and cytokeratin expression in a cultivated limbal autograft used in the treatment of limbal stem cell deficiency. Br J Ophthalmol. 2004;88:1154-8.
6. Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R, De Luca M. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet. 1997;349:990-3.
7. Schwab IR. Cultured corneal epithelia for ocular surface disease. Trans Am Ophthalmol Soc. 1999;97:891-986.
8. Polisetty N, Fatima A, Madhira SL, Sangwan VS, Vemuganti GK. Mesenchymal cells from limbal stroma of human eye. Molec Vision. 2008;14:431-42.
9. Ainscough SL, Linn ML, Barnard Z, Schwab IR, Harkin DG. Effects of fibroblast origin and phenotype on the proliferative potential of limbal epithelial progenitor cells. Exp Eye Res. 2011;92:10-9.
10. Choong PF, Mok PL, Cheong SK, Then KY. Mesenchymal stromal cell-like characteristics of corneal keratocytes. Cytotherapy. 2007;9:252-8.
11. Du Y, Funderburgh ML, Mann MM, SundarRaj N, Funderburgh JL. Multipotent stem cells in human corneal stroma. Stem Cells (Dayton, Ohio). 2005;23:1266-75.
12. Funderburgh ML, Mann MM, Funderburgh JL. Keratocyte phenotype is enhanced in the absence of attachment to the substratum. Molec Vision. 2008;14:308-17.
13. Kawakita T, Espana EM, He H, Smiddy R, Parel JM, Liu CY, et al. Preservation and expansion of the primate keratocyte phenotype by downregulating TGF-beta signaling in a lowcalcium, serum-free medium. Invest Ophthalmol Visual Sci. 2006;47:1918-27.
14. Mimura T, Amano S, Yokoo S, Uchida S, Yamagami S, Usui T, et al. Tissue engineering of corneal stroma with rabbit fibroblast precursors and gelatin hydrogels. Molec Vision. 2008;14:1819-28.
15. Brooke G, Cook M, Blair C, Han R, Heazlewood C, Jones B, et al. Therapeutic applications of mesenchymal stromal cells. Sem Cell Devel Biol. 2007;18:846-58.
16. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7.
17. Joseph A, Hossain P, Jham S, Jones RE, Tighe P, McIntosh RS, et al. Expression of CD34 and L-selectin on human corneal keratocytes. Invest Ophthalmol Visual Sci. 2003;44:4689-92.
18. Toti P, Tosi GM, Traversi C, Schurfeld K, Cardone C, Caporossi A. CD34 stromal expression pattern in normal and altered human corneas. Ophthalmology. 2002;109:1167-71.
19. Raife TJ, Lager DJ, Madison KC, Piette WW, Howard EJ, Sturm MT, et al. Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation. J Clin Invest. 1994;93:1846-51.
20. Mizutani H, Hayashi T, Nouchi N, Ohyanagi S, Hashimoto K, Shimizu M, et al. Functional and immunoreactive thrombomodulin expressed by keratinocytes. J Invest Dermatol. 1994;103:825-8.
21. Chirila TV, Barnard Z, Zainuddin, Harkin DG, Schwab IR, Hirst LW. Bombyx mori silk fibroin membranes as potential substrata for epithelial constructs used in the management of ocular surface disorders. Tissue Eng. 2008;14:1203-11.
22. Rama P, Matuska S, Paganoni G, Spinelli A, De Luca M, Pellegrini G. Limbal stem-cell therapy and long-term corneal regeneration. New Engl J Med. 2010;363:147-55.
23. Pal R, Hanwate M, Jan M, Totey S. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med. 2009;3:163-74.
24. Boffa MC, Karmochkine M. Thrombomodulin: an overview and potential implications in vascular disorders. Lupus. 1998;7(Suppl 2):S120-5.
25. Omoto M, Miyashita H, Shimmura S, Higa K, Kawakita T, Yoshida S, et al. The use of human mesenchymal stem cellderived feeder cells for the cultivation of transplantable epithelial sheets. Invest Ophthalmol Visual Sci. 2009;50:2109-15.